Open AccessPre–Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis
Author(s) -
Richard Castillo,
N. Pham,
Edward Castillo,
S. Aso-González,
Shoaib Ansari,
Brian P. Hobbs,
Diana Palacio,
Heath D. Skinner,
Thomas Guerrero
Publication year - 2015
Publication title -
radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.118
H-Index - 295
eISSN - 1527-1315
pISSN - 0033-8419
DOI - 10.1148/radiol.14140457
Subject(s) - medicine , common terminology criteria for adverse events , radiation therapy , confidence interval , receiver operating characteristic , nuclear medicine , lung cancer , fluorodeoxyglucose , logistic regression , retrospective cohort study , odds ratio , positron emission tomography
To examine the association between pre-radiation therapy (RT) fluorine 18 fluorodeoxyglucose (FDG) uptake and post-RT symptomatic radiation pneumonitis (RP).